US Stock MarketDetailed Quotes

GSTC GLOBESTAR THERAPEUTICS CORP

Watchlist
  • 0.000
  • 0.000-33.33%
15min DelayClose Sep 26 16:00 ET
496.44KMarket Cap-200P/E (TTM)

GLOBESTAR THERAPEUTICS CORP Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
(Q3)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
76.96%-12.38K
-9.35%-42.8K
37.08%-205.76K
-88.10%-72.7K
16.24%-40.18K
51.51%-53.75K
69.78%-39.14K
56.47%-327K
90.82%-38.65K
65.35%-47.96K
Net income from continuing operations
-16.46%-174.96K
1.30%-163.76K
-31.01%-1.95M
-13.71%-350.57K
-711.20%-1.28M
78.18%-150.24K
50.15%-165.91K
84.82%-1.49M
92.77%-308.31K
96.50%-158.1K
Other non cash items
11.94%6.99K
-43.68%5.26K
-87.12%26.67K
67.61%9.61K
-92.45%1.47K
-68.26%6.24K
-94.24%9.34K
-70.19%207.06K
-96.74%5.74K
-49.03%19.45K
Change In working capital
82.26%132.04K
-8.97%90.69K
0.51%446.85K
-34.88%159.75K
50.47%115.03K
-11.31%72.45K
142.43%99.62K
101.15%444.56K
265.95%245.34K
-42.41%76.44K
-Change in prepaid assets
--0
--0
200.00%3.55K
--0
--0
-33.33%2.5K
128.00%1.05K
-174.22%-3.55K
---3.55K
--0
-Change in payables and accrued expense
88.77%132.04K
-8.00%90.69K
-1.07%443.3K
-35.81%159.75K
50.47%115.03K
-10.25%69.95K
119.81%98.57K
107.24%448.11K
258.36%248.89K
-42.41%76.44K
Cash from discontinued investing activities
Operating cash flow
76.96%-12.38K
-9.35%-42.8K
37.08%-205.76K
-88.10%-72.7K
16.24%-40.18K
51.51%-53.75K
69.78%-39.14K
56.47%-327K
90.82%-38.65K
65.35%-47.96K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-73.19%12.38K
5.68%42.8K
-39.10%199.4K
61.54%72.7K
-15.61%40K
-48.67%46.2K
-72.07%40.5K
-51.55%327.4K
-88.92%45K
47.4K
Net issuance payments of debt
--0
--25K
--55K
--40K
--15K
--0
--0
--0
--0
----
Net common stock issuance
118.75%17.5K
250.00%17.5K
1,350.00%72.5K
540.00%32K
--27.5K
--8K
--5K
-99.00%5K
--5K
--0
Net preferred stock issuance
--0
--0
-76.45%73K
--0
--0
-57.78%38K
-75.86%35K
281.54%310K
-91.38%35K
--40K
Net other financing activities
-2,658.00%-5.12K
-40.00%300
-108.91%-1.11K
-86.10%695
---2.5K
--200
--500
--12.4K
--5K
----
Cash from discontinued financing activities
Financing cash flow
-73.19%12.38K
5.68%42.8K
-39.10%199.4K
61.54%72.7K
-15.61%40K
-48.67%46.2K
-72.07%40.5K
-51.55%327.4K
-88.92%45K
--47.4K
Net cash flow
Beginning cash position
--0
--0
6.80%6.37K
--0
-69.44%176
-63.95%7.72K
6.80%6.37K
-92.68%5.96K
-99.94%12
-99.64%576
Current changes in cash
----
----
-1,671.60%-6.37K
--0
68.79%-176
63.80%-7.55K
-91.22%1.36K
100.54%405
143.77%6.35K
99.59%-564
End cash Position
--0
--0
--0
--0
--0
-69.44%176
-63.95%7.72K
6.80%6.37K
6.80%6.37K
-99.94%12
Free cash flow
76.96%-12.38K
-9.35%-42.8K
37.08%-205.76K
-88.10%-72.7K
16.24%-40.18K
51.51%-53.75K
69.78%-39.14K
56.47%-327K
90.82%-38.65K
65.35%-47.96K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022(Q4)Sep 30, 2022(Q3)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 76.96%-12.38K-9.35%-42.8K37.08%-205.76K-88.10%-72.7K16.24%-40.18K51.51%-53.75K69.78%-39.14K56.47%-327K90.82%-38.65K65.35%-47.96K
Net income from continuing operations -16.46%-174.96K1.30%-163.76K-31.01%-1.95M-13.71%-350.57K-711.20%-1.28M78.18%-150.24K50.15%-165.91K84.82%-1.49M92.77%-308.31K96.50%-158.1K
Other non cash items 11.94%6.99K-43.68%5.26K-87.12%26.67K67.61%9.61K-92.45%1.47K-68.26%6.24K-94.24%9.34K-70.19%207.06K-96.74%5.74K-49.03%19.45K
Change In working capital 82.26%132.04K-8.97%90.69K0.51%446.85K-34.88%159.75K50.47%115.03K-11.31%72.45K142.43%99.62K101.15%444.56K265.95%245.34K-42.41%76.44K
-Change in prepaid assets --0--0200.00%3.55K--0--0-33.33%2.5K128.00%1.05K-174.22%-3.55K---3.55K--0
-Change in payables and accrued expense 88.77%132.04K-8.00%90.69K-1.07%443.3K-35.81%159.75K50.47%115.03K-10.25%69.95K119.81%98.57K107.24%448.11K258.36%248.89K-42.41%76.44K
Cash from discontinued investing activities
Operating cash flow 76.96%-12.38K-9.35%-42.8K37.08%-205.76K-88.10%-72.7K16.24%-40.18K51.51%-53.75K69.78%-39.14K56.47%-327K90.82%-38.65K65.35%-47.96K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -73.19%12.38K5.68%42.8K-39.10%199.4K61.54%72.7K-15.61%40K-48.67%46.2K-72.07%40.5K-51.55%327.4K-88.92%45K47.4K
Net issuance payments of debt --0--25K--55K--40K--15K--0--0--0--0----
Net common stock issuance 118.75%17.5K250.00%17.5K1,350.00%72.5K540.00%32K--27.5K--8K--5K-99.00%5K--5K--0
Net preferred stock issuance --0--0-76.45%73K--0--0-57.78%38K-75.86%35K281.54%310K-91.38%35K--40K
Net other financing activities -2,658.00%-5.12K-40.00%300-108.91%-1.11K-86.10%695---2.5K--200--500--12.4K--5K----
Cash from discontinued financing activities
Financing cash flow -73.19%12.38K5.68%42.8K-39.10%199.4K61.54%72.7K-15.61%40K-48.67%46.2K-72.07%40.5K-51.55%327.4K-88.92%45K--47.4K
Net cash flow
Beginning cash position --0--06.80%6.37K--0-69.44%176-63.95%7.72K6.80%6.37K-92.68%5.96K-99.94%12-99.64%576
Current changes in cash ---------1,671.60%-6.37K--068.79%-17663.80%-7.55K-91.22%1.36K100.54%405143.77%6.35K99.59%-564
End cash Position --0--0--0--0--0-69.44%176-63.95%7.72K6.80%6.37K6.80%6.37K-99.94%12
Free cash flow 76.96%-12.38K-9.35%-42.8K37.08%-205.76K-88.10%-72.7K16.24%-40.18K51.51%-53.75K69.78%-39.14K56.47%-327K90.82%-38.65K65.35%-47.96K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data